Search

everythinglearnresearchcommunity

for

Search:↓

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

A man lost all his hair as a rare side effect after hepatitis C treatment.

A patient developed a blister at the injection site after hepatitis C treatment.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Type I interferons play a key role in the development of various skin diseases.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Melatonin improves cashmere goat hair growth and quality by increasing antioxidants and reducing cell death.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Cepharanthine shows promise as a COVID-19 treatment.

Combination therapies might work better for some vitiligo patients, but results vary.